{"transactions":[{"id":1937792,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-27T19:56:09.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":36657,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Robert S. Breuil's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Robert S. Breuil's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Robert S. Breuil's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Robert S. Breuil's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":36657},"source":{"system":"sec-edgar","filing":"0001209191-23-021300","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123021300/doc4.xml","form_type":"4"}},{"id":1937791,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-27T19:56:09.000Z","date":"2023-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":12677,"price":5.5,"value":69723.5,"ownership":{"direct":true},"balance_after":35326,"source":{"system":"sec-edgar","filing":"0001209191-23-021300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123021300/doc4.xml","form_type":"4"}},{"id":1937790,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-27T19:56:09.000Z","date":"2023-03-23","kind":"disposition_to_issuer","planned":false,"acquired":true,"shares":36657,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects a 14-to-1 reverse stock split effective March 17, 2023. Under the terms of the Agreement and Plan of Merger and Reorganization, dated as of November 21, 2022, as amended (the \"Merger Agreement\"), by and among CalciMedica, Inc. (\"Private CalciMedica\"), the Issuer and Camaro Merger Sub, Inc., a wholly-owned subsidiary of the Issuer (\"Merger Sub\"), on March 20, 2023, Merger Sub merged with and into Private CalciMedica (the \"Merger\"), with Private CalciMedica surviving the Merger as a wholly-owned subsidiary of the Issuer. Upon the closing of the Merger, each share of CalciMedica common capital stock was converted into the right to receive 0.0288 of a share of the Issuer's common stock. Subsequent to the Merger, the name of the Issuer was changed from Graybug Vision, Inc. to CalciMedica, Inc. In connection with the Merger, the vesting of Robert S. Breuil's options and restricted stock units (\"RSUs\") were fully accelerated and the RSUs were settled on March 23, 2023."}],"balance_after":48003,"source":{"system":"sec-edgar","filing":"0001209191-23-021300","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123021300/doc4.xml","form_type":"4"}},{"id":1951946,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-15T16:15:09.000Z","date":"2023-03-14","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on September 4, 2021, and 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":30000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-23-018885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123018885/doc4.xml","form_type":"4"}},{"id":1951945,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-15T16:15:09.000Z","date":"2023-03-14","kind":"tax_withholding","acquired":false,"shares":1730,"price":0.58,"value":1003.4,"ownership":{"direct":true},"balance_after":162119,"source":{"system":"sec-edgar","filing":"0001209191-23-018885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123018885/doc4.xml","form_type":"4"}},{"id":1951944,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-15T16:15:09.000Z","date":"2023-03-14","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":163849,"source":{"system":"sec-edgar","filing":"0001209191-23-018885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123018885/doc4.xml","form_type":"4"}},{"id":1968701,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-06T18:59:09.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":393750,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-23-016509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123016509/doc4.xml","form_type":"4"}},{"id":1968700,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2023-03-06T18:59:09.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":83155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs shall vested as to 100% of the total RSUs on February 28, 2023 and settled on March 3, 2023, subject to the Reporting Person's provision of service to the Issuer on each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":83155},"source":{"system":"sec-edgar","filing":"0001209191-23-016509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123016509/doc4.xml","form_type":"4"}},{"id":1968699,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-06T18:59:09.000Z","date":"2023-03-03","kind":"exercise","acquired":false,"shares":9937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":89438,"derivative":{"underlying":"Common Stock","underlying_shares":9937},"source":{"system":"sec-edgar","filing":"0001209191-23-016509","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123016509/doc4.xml","form_type":"4"}},{"id":1968698,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T18:59:09.000Z","date":"2023-03-03","kind":"tax_withholding","acquired":false,"shares":49434,"price":0.57,"value":28177.38,"ownership":{"direct":true},"balance_after":158849,"source":{"system":"sec-edgar","filing":"0001209191-23-016509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123016509/doc4.xml","form_type":"4"}},{"id":1968697,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-03-06T18:59:09.000Z","date":"2023-03-03","kind":"exercise","acquired":true,"shares":121217,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":208283,"source":{"system":"sec-edgar","filing":"0001209191-23-016509","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919123016509/doc4.xml","form_type":"4"}},{"id":2086333,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-14T16:07:56.000Z","date":"2022-12-12","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on September 4, 2021, and 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":35000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-061177","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122061177/doc4.xml","form_type":"4"}},{"id":2086332,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T16:07:56.000Z","date":"2022-12-12","kind":"tax_withholding","acquired":false,"shares":1729,"price":0.58,"value":1002.82,"ownership":{"direct":true},"balance_after":87066,"source":{"system":"sec-edgar","filing":"0001209191-22-061177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122061177/doc4.xml","form_type":"4"}},{"id":2086331,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-14T16:07:56.000Z","date":"2022-12-12","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":88795,"source":{"system":"sec-edgar","filing":"0001209191-22-061177","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122061177/doc4.xml","form_type":"4"}},{"id":2099833,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-12-01T16:50:59.000Z","date":"2022-12-01","kind":"exercise","acquired":false,"shares":9938,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":99375,"derivative":{"underlying":"Common Stock","underlying_shares":9938},"source":{"system":"sec-edgar","filing":"0001209191-22-059207","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122059207/doc4.xml","form_type":"4"}},{"id":2099832,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-01T16:50:59.000Z","date":"2022-12-01","kind":"tax_withholding","acquired":false,"shares":3437,"price":0.63,"value":2165.31,"ownership":{"direct":true},"balance_after":83795,"source":{"system":"sec-edgar","filing":"0001209191-22-059207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122059207/doc4.xml","form_type":"4"}},{"id":2099831,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-12-01T16:50:59.000Z","date":"2022-12-01","kind":"exercise","acquired":true,"shares":9938,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87232,"source":{"system":"sec-edgar","filing":"0001209191-22-059207","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122059207/doc4.xml","form_type":"4"}},{"id":2102307,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-11-29T16:38:35.000Z","date":"2022-11-24","kind":"exercise","acquired":false,"shares":28125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vested as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":421875,"derivative":{"underlying":"Common Stock","underlying_shares":28125},"source":{"system":"sec-edgar","filing":"0001209191-22-058951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122058951/doc4.xml","form_type":"4"}},{"id":2102306,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T16:38:35.000Z","date":"2022-11-24","kind":"tax_withholding","acquired":false,"shares":9726,"price":0.67,"value":6516.42,"ownership":{"direct":true},"balance_after":77294,"source":{"system":"sec-edgar","filing":"0001209191-22-058951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122058951/doc4.xml","form_type":"4"}},{"id":2102305,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-11-29T16:38:35.000Z","date":"2022-11-24","kind":"exercise","acquired":true,"shares":28125,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":87020,"source":{"system":"sec-edgar","filing":"0001209191-22-058951","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122058951/doc4.xml","form_type":"4"}},{"id":2151188,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-26T16:17:54.000Z","date":"2022-09-04","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/12 of the total shares on September 4, 2022, but were not settled and issued until September 23, 2022.  1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":40000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-051242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122051242/doc4.xml","form_type":"4"}},{"id":2151187,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-26T16:17:54.000Z","date":"2022-09-23","kind":"tax_withholding","acquired":false,"shares":1684,"price":0.9661,"value":1626.9124,"ownership":{"direct":true},"balance_after":58895,"source":{"system":"sec-edgar","filing":"0001209191-22-051242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122051242/doc4.xml","form_type":"4"}},{"id":2151186,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-09-26T16:17:54.000Z","date":"2022-09-04","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":60579,"source":{"system":"sec-edgar","filing":"0001209191-22-051242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122051242/doc4.xml","form_type":"4"}},{"id":2172757,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-26T16:49:59.000Z","date":"2022-08-24","kind":"grant","acquired":true,"shares":450000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest as to 6.25% of the total shares on November 16, 2022, and 6.25% of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on August 16, 2026, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":450000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":450000},"source":{"system":"sec-edgar","filing":"0001209191-22-047724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122047724/doc4.xml","form_type":"4"}},{"id":2175983,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-08-23T17:17:43.000Z","date":"2022-08-19","kind":"exercise","acquired":false,"shares":9937,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":109313,"derivative":{"underlying":"Common Stock","underlying_shares":9937},"source":{"system":"sec-edgar","filing":"0001209191-22-047234","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122047234/doc4.xml","form_type":"4"}},{"id":2175982,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-23T17:17:43.000Z","date":"2022-08-19","kind":"tax_withholding","acquired":false,"shares":3347,"price":0.97,"value":3246.59,"ownership":{"direct":true},"balance_after":55579,"source":{"system":"sec-edgar","filing":"0001209191-22-047234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122047234/doc4.xml","form_type":"4"}},{"id":2175981,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-08-23T17:17:43.000Z","date":"2022-08-19","kind":"exercise","acquired":true,"shares":9937,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":58926,"source":{"system":"sec-edgar","filing":"0001209191-22-047234","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122047234/doc4.xml","form_type":"4"}},{"id":2233887,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-06-13T17:06:26.000Z","date":"2022-06-09","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on September 4, 2021 but did not settle until September 22, 2021.  1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":45000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-036381","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122036381/doc4.xml","form_type":"4"}},{"id":2233886,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-06-13T17:06:26.000Z","date":"2022-06-09","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":48989,"source":{"system":"sec-edgar","filing":"0001209191-22-036381","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122036381/doc4.xml","form_type":"4"}},{"id":2259706,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-05-23T16:48:17.000Z","date":"2022-05-19","kind":"exercise","acquired":false,"shares":39750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":119250,"derivative":{"underlying":"Common Stock","underlying_shares":39750},"source":{"system":"sec-edgar","filing":"0001209191-22-031353","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122031353/doc4.xml","form_type":"4"}},{"id":2259705,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-23T16:48:17.000Z","date":"2022-05-19","kind":"tax_withholding","acquired":false,"shares":16290,"price":0.9011,"value":14678.919,"ownership":{"direct":true},"balance_after":43989,"source":{"system":"sec-edgar","filing":"0001209191-22-031353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122031353/doc4.xml","form_type":"4"}},{"id":2259704,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-05-23T16:48:17.000Z","date":"2022-05-19","kind":"exercise","acquired":true,"shares":39750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":60279,"source":{"system":"sec-edgar","filing":"0001209191-22-031353","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122031353/doc4.xml","form_type":"4"}},{"id":2307757,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-04T17:41:07.000Z","date":"2022-03-31","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested as to 1/12 of the total shares on March 4, 2022, but were not settled and issued until March 31, 2022.  1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":50000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-22-022591","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122022591/doc4.xml","form_type":"4"}},{"id":2307756,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-04T17:41:07.000Z","date":"2022-03-31","kind":"sale","acquired":false,"shares":2188,"price":1.25,"value":2735.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the\nRestricted Stock Units (\"RSUs\"). The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other\nthan to cover required taxes and fees."}],"balance_after":20529,"source":{"system":"sec-edgar","filing":"0001209191-22-022591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122022591/doc4.xml","form_type":"4"}},{"id":2307755,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2022-04-04T17:41:07.000Z","date":"2022-03-31","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":22717,"source":{"system":"sec-edgar","filing":"0001209191-22-022591","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122022591/doc4.xml","form_type":"4"}},{"id":2360033,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Unit","published_at":"2022-03-02T18:55:32.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":83155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vests as to 100% of the total RSUs on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vests as to 100% of the total RSUs on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":83155,"derivative":{"underlying":"Common Stock","underlying_shares":83155},"source":{"system":"sec-edgar","filing":"0001209191-22-015048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122015048/doc4.xml","form_type":"4"}},{"id":2360032,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-03-02T18:55:32.000Z","date":"2022-02-28","kind":"grant","acquired":true,"shares":63845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 100% of the total shares on February 28, 2023, subject to the Reporting Person's provision of service to the Issuer on the vesting date."}],"balance_after":63845,"derivative":{"exercise_price":1.33,"expiration_date":"2032-02-27","underlying":"Common Stock","underlying_shares":63845},"source":{"system":"sec-edgar","filing":"0001209191-22-015048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919122015048/doc4.xml","form_type":"4"}},{"id":2482019,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-12-07T18:52:40.000Z","date":"2021-12-04","kind":"exercise","acquired":false,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested as to 1/4 of the total shares on September 4, 2021 but did not settle until September 22, 2021.  1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":55000,"derivative":{"underlying":"Common Stock","underlying_shares":5000},"source":{"system":"sec-edgar","filing":"0001209191-21-068421","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121068421/doc4.xml","form_type":"4"}},{"id":2482018,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-12-07T18:52:40.000Z","date":"2021-12-04","kind":"exercise","acquired":true,"shares":5000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":17717,"source":{"system":"sec-edgar","filing":"0001209191-21-068421","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121068421/doc4.xml","form_type":"4"}},{"id":2559879,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-09-24T19:16:09.000Z","date":"2021-09-22","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested as to 1/4 of the total shares on September 4, 2021, but were not settled and issued until September 22, 2021.  1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":60000,"derivative":{"underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001209191-21-057712","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121057712/doc4.xml","form_type":"4"}},{"id":2559878,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-24T19:16:09.000Z","date":"2021-09-22","kind":"sale","acquired":false,"shares":7283,"price":3.5499,"value":25853.9217,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the\nRestricted Stock Units (\"RSUs\"). The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other\nthan to cover required taxes and fees."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.47 to\n$3.61 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the\nSecurities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the\nrange set forth in this footnote."}],"balance_after":12717,"source":{"system":"sec-edgar","filing":"0001209191-21-057712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121057712/doc4.xml","form_type":"4"}},{"id":2559877,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2021-09-24T19:16:09.000Z","date":"2021-09-22","kind":"exercise","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":20000,"source":{"system":"sec-edgar","filing":"0001209191-21-057712","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121057712/doc4.xml","form_type":"4"}},{"id":2700596,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2021-05-21T16:21:21.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":159000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest as to 1/4 of the total shares on May 19, 2022, and 1/16 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on May 19, 2025, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":159000,"derivative":{"underlying":"Common Stock","underlying_shares":159000},"source":{"system":"sec-edgar","filing":"0001209191-21-034906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121034906/doc4.xml","form_type":"4"}},{"id":2700595,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-05-21T16:21:21.000Z","date":"2021-05-19","kind":"grant","acquired":true,"shares":232000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/4 of the total shares on May 19, 2022 and then 1/48 of the total shares monthly until the option is fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":232000,"derivative":{"exercise_price":3.73,"expiration_date":"2031-05-18","underlying":"Common Stock","underlying_shares":232000},"source":{"system":"sec-edgar","filing":"0001209191-21-034906","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919121034906/doc4.xml","form_type":"4"}},{"id":2949934,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-12-10T17:08:50.000Z","date":"2020-12-08","kind":"grant","acquired":true,"shares":30000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests as to 1/48 of the total shares on January 8, 2021 and each month thereafter until option is fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date."}],"balance_after":30000,"derivative":{"exercise_price":23.66,"expiration_date":"2030-12-07","underlying":"Common Stock","underlying_shares":30000},"source":{"system":"sec-edgar","filing":"0001209191-20-062751","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919120062751/doc4.xml","form_type":"4"}},{"id":3021628,"issuer":{"id":7804,"kind":"organization","name":"CalciMedica, Inc.","symbol":"CALC"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2020-09-28T17:38:34.000Z","date":"2020-09-24","kind":"grant","acquired":true,"shares":80000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs shall vest as to 1/4 of the total shares on September 4, 2021, and 1/12 of the remaining shares shall vest quarterly thereafter such that the RSUs shall be fully vested on September 4, 2024, subject to the continued service of the Reporting Person to the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs do not expire; they either vest or are canceled prior to vest date."}],"balance_after":80000,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":80000},"source":{"system":"sec-edgar","filing":"0001209191-20-052240","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000120919120052240/doc4.xml","form_type":"4"}},{"id":3750209,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":8750,"price":12.5,"value":109375.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750208,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":8437,"price":12.5,"value":105462.5,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."},{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested RSU outstanding that had not yet been settled was converted into and substituted for the right to receive an amount equal to the product of (x) the number of Shares issuable under such RSU multiplied by $12.50. This consideration will be paid annually in accordance with the annual vesting schedule that originally was applicable to such RSU."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":8437},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750207,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":29896,"price":12.5,"value":373700.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":29896},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750206,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":18118,"price":12.5,"value":226475.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":18118},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750205,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":1042,"price":12.5,"value":13025.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":1042},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750204,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":1771,"price":12.5,"value":22137.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":5.5,"expiration_date":"2024-12-02","underlying":"Common Stock","underlying_shares":1771},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750203,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":10573,"price":12.5,"value":132162.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":10573},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750202,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":17038,"price":12.5,"value":212975.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":17038},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750201,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12500,"price":12.5,"value":156250.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750200,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":12031,"price":12.5,"value":150387.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":12031},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750199,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":32344,"price":12.5,"value":404300.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":32344},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750198,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":36458,"price":12.5,"value":455725.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each unvested option to purchase Shares that was unexpired, unexercised and outstanding was converted into and substituted for the right to receive an amount equal to the product of (x) the number of unvested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option. This consideration will be paid monthly in accordance with the monthly vesting schedule that originally was applicable to such option."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":7.94,"expiration_date":"2025-12-07","underlying":"Common Stock","underlying_shares":36458},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750197,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":55346,"price":12.5,"value":691825.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.5,"expiration_date":"2024-12-02","underlying":"Common Stock","underlying_shares":55346},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750196,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":23621,"price":12.5,"value":295262.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.141,"expiration_date":"2024-01-26","underlying":"Common Stock","underlying_shares":23621},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750195,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":10688,"price":12.5,"value":133600.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.222,"expiration_date":"2022-12-12","underlying":"Common Stock","underlying_shares":10688},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750194,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":27883,"price":12.5,"value":348537.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":5.5,"expiration_date":"2024-12-02","underlying":"Common Stock","underlying_shares":27883},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750193,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":17962,"price":12.5,"value":224525.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":4.141,"expiration_date":"2024-01-26","underlying":"Common Stock","underlying_shares":17962},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750192,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":167529,"price":12.5,"value":2094112.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested."}],"balance_after":0,"derivative":{"exercise_price":2.222,"expiration_date":"2022-12-12","underlying":"Common Stock","underlying_shares":167529},"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3750191,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-11-28T19:49:13.000Z","date":"2018-11-27","kind":"disposition_to_issuer","acquired":false,"shares":14441,"price":12.5,"value":180512.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the \"Merger Agreement\"), between Corium International, Inc. (the \"Company\"), Gurnet Holding Company (\"Parent\") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent (\"Merger Sub\"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the \"Merger\"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a \"Share\") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a \"CVR\")."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001567619-18-007063","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918007063/doc1.xml","form_type":"4"}},{"id":3839681,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units (RSU)","published_at":"2018-08-17T20:14:36.000Z","date":"2018-08-17","kind":"exercise","acquired":false,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The RSUs vest as to 1/4 of the total number of shares on January 4, 2018 and then 1/4 of the total number of shares on January 4 of each successive year thereafter, subject    to the Issuer's Insider Trading Policy and trading window and to the reporting person's continued service with the Issuer through each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The RSUs vest as to 1/4 of the total number of shares on January 4, 2018 and then 1/4 of the total number of shares on January 4 of each successive year thereafter, subject    to the Issuer's Insider Trading Policy and trading window and to the reporting person's continued service with the Issuer through each vesting date."}],"balance_after":8437,"derivative":{"underlying":"Common Stock","underlying_shares":2813},"source":{"system":"sec-edgar","filing":"0001567619-18-001418","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918001418/doc1.xml","form_type":"4"}},{"id":3839680,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:14:36.000Z","date":"2018-08-17","kind":"sale","acquired":false,"shares":972,"price":9.0086,"value":8756.3592,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units (\"RSUs\") listed in Table II. This sale is mandated by the Issuer's election under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.59 to $9.16 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":14441,"source":{"system":"sec-edgar","filing":"0001567619-18-001418","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918001418/doc1.xml","form_type":"4"}},{"id":3839679,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2018-08-17T20:14:36.000Z","date":"2018-08-17","kind":"exercise","acquired":true,"shares":2813,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,000 shares acquired under the Issuer's employee stock purchase plan on May 18, 2018."}],"balance_after":15413,"source":{"system":"sec-edgar","filing":"0001567619-18-001418","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000156761918001418/doc1.xml","form_type":"4"}},{"id":4141689,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2017-12-05T19:33:07.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted stock unit (\"RSUs\") represents the contingent right to receive one share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vest as to 1/4 of the total number of shares on December 1, 2018 and then 1/4 of the total number of shares on December 1 of each successive year thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vest as to 1/4 of the total number of shares on December 1, 2018 and then 1/4 of the total number of shares on December 1 of each successive year thereafter."}],"balance_after":8750,"derivative":{"underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001140361-17-045099","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000114036117045099/doc1.xml","form_type":"4"}},{"id":4141688,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-12-05T19:33:07.000Z","date":"2017-12-01","kind":"grant","acquired":true,"shares":52500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests as to 1/48th of the total number of shares on January 1, 2018 and then 1/48th monthly thereafter."}],"balance_after":52500,"derivative":{"exercise_price":11.59,"expiration_date":"2027-11-30","underlying":"Common Stock","underlying_shares":52500},"source":{"system":"sec-edgar","filing":"0001140361-17-045099","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000114036117045099/doc1.xml","form_type":"4"}},{"id":4511772,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2016-12-27T17:29:52.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":67500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option vests as to 1/48th of the total number of shares on January 22, 2017 and then 1/48th monthly thereafter."}],"balance_after":67500,"derivative":{"exercise_price":4.59,"expiration_date":"2026-12-21","underlying":"Common Stock","underlying_shares":67500},"source":{"system":"sec-edgar","filing":"0001140361-16-090832","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000114036116090832/doc1.xml","form_type":"4"}},{"id":4511771,"issuer":{"id":162158,"kind":"organization","name":"Corium International, Inc.","symbol":"CORI"},"owners":[{"id":115115,"kind":"person","name":"BREUIL ROBERT S","position":1,"cik":"0001241009","reported_name":"BREUIL ROBERT S","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Restricted Stock Units","published_at":"2016-12-27T17:29:52.000Z","date":"2016-12-22","kind":"grant","acquired":true,"shares":11250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (\"RSU\") represents the contingent right to receive one share of the issuer's common stock upon settlement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest as to 1/4 of the total number of shares on January 4, 2018 and then 1/4 of the total number of shares on January 4 of each successive year thereafter."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest as to 1/4 of the total number of shares on January 4, 2018 and then 1/4 of the total number of shares on January 4 of each successive year thereafter."}],"balance_after":11250,"derivative":{"underlying":"Common Stock","underlying_shares":11250},"source":{"system":"sec-edgar","filing":"0001140361-16-090832","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1241009/000114036116090832/doc1.xml","form_type":"4"}}]}